| dc.creator | Vavougios G.D., Zarogiannis S.G. | en |
| dc.date.accessioned | 2023-01-31T10:30:47Z | |
| dc.date.available | 2023-01-31T10:30:47Z | |
| dc.date.issued | 2017 | |
| dc.identifier | 10.21037/jtd.2017.04.35 | |
| dc.identifier.issn | 20721439 | |
| dc.identifier.uri | http://hdl.handle.net/11615/80541 | |
| dc.description.abstract | [No abstract available] | en |
| dc.language.iso | en | en |
| dc.source | Journal of Thoracic Disease | en |
| dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019738063&doi=10.21037%2fjtd.2017.04.35&partnerID=40&md5=66c27b2f861c72825e926da626963bb0 | |
| dc.subject | 4 (4 chlorophenyl) 2,3,9 trimethyl 6h thieno[3,2 f][1,2,4]triazolo[4,3 a][1,4]diazepine 6 acetic acid tert butyl ester | en |
| dc.subject | cyclic AMP responsive element binding protein | en |
| dc.subject | mammalian target of rapamycin | en |
| dc.subject | mammalian target of rapamycin complex 1 | en |
| dc.subject | mammalian target of rapamycin inhibitor | en |
| dc.subject | mitogen activated protein kinase | en |
| dc.subject | mitogen activated protein kinase p38 | en |
| dc.subject | Myc protein | en |
| dc.subject | phosphatidylinositol 3 kinase | en |
| dc.subject | protein tyrosine kinase | en |
| dc.subject | Ras protein | en |
| dc.subject | transcription factor Yap1 | en |
| dc.subject | cancer inhibition | en |
| dc.subject | cancer resistance | en |
| dc.subject | carcinogenesis | en |
| dc.subject | drug targeting | en |
| dc.subject | Editorial | en |
| dc.subject | enzyme inhibition | en |
| dc.subject | gene mutation | en |
| dc.subject | human | en |
| dc.subject | nonhuman | en |
| dc.subject | pathophysiology | en |
| dc.subject | signal transduction | en |
| dc.subject | tumor escape | en |
| dc.subject | tumor growth | en |
| dc.subject | AME Publishing Company | en |
| dc.title | MYCing and YAPing the escape of tumor cell growth arrest after chronic PI3K/mTOR inhibition | en |
| dc.type | other | en |